A Framework for Individualizing Predictions of Disease Trajectories by Exploiting Multi-Resolution Structure [PDF]
arXiv, 2016 For many complex diseases, there is a wide variety of ways in which an individual can manifest the disease. The challenge of personalized medicine is to develop tools that can accurately predict the trajectory of an individual's disease, which can in turn enable clinicians to optimize treatments.
arxiv
Einfluss der Art der Materialgewinnung auf die Diagnosefindung in der Lungenpathologie [PDF]
, 2019 Das Ziel der Arbeit ist die Darstellung der Möglichkeiten der Kryobiopsien für die Diagnostik von Lungenerkrankungen und Pleuraerkrankungen. Es wurde zunächst gezeigt, dass die transbronchialen Kryobiopsien einen deutlichen morphologischen Unterschied ...
Griff, Sergej
core +1 more source
Pulmonary lymphangiomatosis: insights into an ultra-rare disease
Respiratory ResearchBackground Pulmonary lymphangiomatosis (PL) is an ultrarare disease characterized by diffuse infiltration of the lung, pleura and/or mediastinum by abnormal lymphatic proliferation. Consented diagnostic or treatment approaches are not established.
M. Polke +13 more
doaj +1 more source
Lung surfactant in subacute pulmonary disease [PDF]
, 2002 Pulmonary surfactant is a surface active material composed of both lipids and proteins that is produced by alveolar type II pneumocytes. Abnormalities of surfactant in the immature lung or in the acutely inflamed mature lung are well described.
A Anzueto +30 more
core +4 more sources
Bilateral Vocal Cord Carcinoma in a Sarcoidosis Patient during Infliximab Therapy
Case Reports in Pulmonology, 2013 Introduction. Although the role of TNF-α in tumor development is not fully understood, an increased risk of malignancy with TNF-α-inhibitors, such as infliximab, has been suggested. Case Presentation.
Adriane D. M. Vorselaars +3 more
doaj +1 more source
Prognosis and longitudinal changes of physical activity in idiopathic pulmonary fibrosis
BMC Pulmonary Medicine, 2017 Background Physical activity (PA) is associated with disease severity in idiopathic pulmonary fibrosis (IPF), but longitudinal studies evaluating its prognostic value and changes over time are lacking.
Thomas Bahmer +10 more
doaj +1 more source
Mindfulness-based stress reduction in patients with interstitial lung diseases: a pilot, single-centre observational study on safety and efficacy [PDF]
, 2015 open11siBackground Chronic, progressive respiratory symptoms are associated with great psychological and emotional impact in patients suffering from interstitial lung disease (ILD).
CERRI, Stefania +10 more
core +1 more source
BMC Pulmonary Medicine, 2019 Background Fibrosing, non-idiopathic pulmonary fibrosis (non-IPF) interstitial lung diseases (fILDs) are a heterogeneous group of diseases characterized by a different amount of inflammation and fibrosis. Therapy is currently based on corticosteroids and/
Sebastiano Emanuele Torrisi +13 more
doaj +1 more source
Imatinib-induced interstitial pneumonitis – a literature review and case report [PDF]
, 2020 Imatinib is generally well tolerated, with mild common side effects such as nausea and vomiting, diarrhea, muscle cramps, fatigue, skin rash and edema; however, pulmonary complications are uncommon. A 73-year-old woman undergoing one month treatment with
Ciulei, George +12 more
core +1 more source
Increased levels of hyaluronic acid in bronchoalveolar lavage from patients with interstitial lung diseases, relationship with lung function and inflammatory cells recruitment [PDF]
, 2014 Purpose: Interstitial Lung Diseases (ILD) are characterized by inflammation and fibrosis. It described the role of hyaluronic acid (HA) as an immune-regulator. It is not known if HA contributes to the recruitment of inflammatory cells associated with ILD.
Auteri, Santiago +6 more
core +1 more source